Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17607279 | 1.00 | OPRM1 (0.49) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL17730835 | 1.00 | OPRM1 (0.49) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL17731291 | 1.00 | OPRM1 (0.49) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL17607210 | 1.00 | OPRM1 (0.49) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL4437885 | 0.97 | — | — | |
| SCHEMBL28957502 | 0.90 | OPRM1 (0.46) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL7163027 | 0.90 | OPRM1 (0.46) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL10442021 | 0.90 | OPRM1 (0.46) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL5169885 | 0.89 | — | — | |
| SCHEMBL25227088 | 0.88 | OPRM1 (0.45) | OPRM1OPRD1OPRK1OPRL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109846733-A | A kind of root of Dahurain angelica mildy wash and its preparation process | 陈善堂生物制药有限责任公司 | 2019-06-07 | — | — | CN | claimed |
| WO-2017061971-A1 | TOPICAL MINOXIDIL COMPOSITION | ASSOS ILAÇ KIMYA GIDA ÜRÜNLERI ÜRETIM VE TIC. A. Ş. (TR) | 2017-04-13 | — | — | WO | claimed |
| EP-3875097-B1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | NEXTPHASE THERAPEUTICS INC (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-3875097-A1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | Mariñas Pardo, Luis (ES) | 2021-09-08 | — | — | EP | disclosed |
| US-20210244767-A1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | NextPhase Therapeutics, Inc. | 2021-08-12 | — | — | US | disclosed |
| US-20210236560-A1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | NextPhase Therapeutics, Inc. | 2021-08-05 | — | — | US | disclosed |
| EP-3806872-A1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | Mariñas Pardo, Luis (ES) | 2021-04-21 | — | — | EP | disclosed |
| EP-3359198-B1 | TOPICAL MINOXIDIL COMPOSITION | ASSOS ILAC KIMYA GIDA UERUENLERI UERETIM VE TIC A S (TR) | 2020-05-13 | — | — | EP | disclosed |
| WO-2019238952-A1 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | MARINAS PARDO LUIS (ES) | 2019-12-19 | — | — | WO | disclosed |
| US-20190083492-A1 | TOPICAL MINOXIDIL COMPOSITION | ASSOS ILAÇ KIMYA GIDA ÜRÜNLERI ÜRETIM VE TIC. A. ? . (TR) | 2019-03-21 | — | — | US | disclosed |
| CN-108929803-A | Strong dirt-removing house detergent | 常州市新晞电气制造有限公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-108728268-A | Less toxic house detergent | 柏建华 | 2018-11-02 | — | — | CN | disclosed |
| WO-2017061971-A1 | TOPICAL MINOXIDIL COMPOSITION | ASSOS ILAÇ KIMYA GIDA ÜRÜNLERI ÜRETIM VE TIC. A. Ş. (TR) | 2017-04-13 | — | — | WO | disclosed |
| EP-2493462-A1 | PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURES | Green Molecular, S.L. (ES) | 2012-09-05 | — | — | EP | disclosed |
| EP-2488548-A1 | A LOW DENSITY LIPOPROTEIN-RELATED PROTEIN 1 SPLICE VARIANT AS CANCER MARKER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung (DE) | 2012-08-22 | — | — | EP | disclosed |
| WO-2011054644-A1 | A LOW DENSITY LIPOPROTEIN-RELATED PROTEIN 1 SPLICE VARIANT AS CANCER MARKER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2011-05-12 | — | — | WO | disclosed |
| WO-2011051483-A1 | PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURES | GREEN MOLECULAR, S.L (ES) | 2011-05-05 | — | — | WO | disclosed |
| WO-2001089488-A1 | PLASTER CONTAINING ESTROGEN, WITH AN ACTIVE AGENT RESERVOIR BASED ON ETHYLCELLULOSE, POLYOXYETHYLENE LAURYL ALCOHOL AND AN ETHYLENE-VINYLACETATE-VINYLPYRROLIDONE COPOLYMER | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190083492-A1 | TOPICAL MINOXIDIL COMPOSITION | MCOLN3, ACADVL, MCOLN1 | OPRM1 1342/4885OPRD1 675/4885OPRK1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.